In the BioHarmony Drug Report Database
Secretin
Secretin-ferring (secretin) is a protein pharmaceutical. Secretin was first approved as Secretin-ferring on 1982-01-01. The pharmaceutical is active against secretin receptor. In addition, it is known to target pituitary adenylate cyclase-activating polypeptide type I receptor, vasoactive intestinal polypeptide receptor 2, and vasoactive intestinal polypeptide receptor 1.
Trade Name
|
Secretin-ferring |
|---|---|
Common Name
|
secretin |
ChEMBL ID
|
CHEMBL3039582 |
Indication
|
|
Drug Class
|
Retinol derivatives |
Image (chem structure or protein)